Richard A. Heyman, Director: Oric Pharmaceuticals ORIC Sell · Filed 10/02

Trade details

Type: Insider sale
Amount: $45,199.35
Shares · price: 3,500 sh · $12.91 a share
Held after: 38,300 sh
Stock: Oric Pharmaceuticals ORIC
Person: Richard A. HeymanDirector
Trade date: 26/10/01
Filed: 26/10/02
Days to filing: 1 days

Sold 8.4% of holdings

Share of holding sold: 8.4%

Oric Pharmaceuticals trades, last 26 weeks

What else happened in Oric Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 09/01~10/31

Richard A. Heyman's recent trades

Richard A. HeymanDirector
Sell10b5-1 planOric Pharmaceuticals
Sell10b5-1 plan
Oric Pharmaceuticals
ORIC
$41.3K
3,200 sh
$41.3K
Filed 10/02
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$109.1K
8,100 sh
$109.1K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$102.4K
7,600 sh
$102.4K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$2.3M
38,000 sh
$2.3M
Filed 09/04
Traded 09/04
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$84K
7,000 sh
$84K
Filed 07/06
Traded 07/06